about
Interventions for managing advanced liver disease in cystic fibrosisPortacaval shunt established in six dogs using magnetic compression technique.Portal hypertension as immune mediate disease.Advances in the management of childhood portal hypertension.Interventions for preventing and managing advanced liver disease in cystic fibrosis.Portal pressure and blood nitric oxide levels as predictors of outcome in biliary atresiaPediatric portal hypertension: A review for primary care
P2860
Q24186697-3891CD2E-6EE2-4A89-B5CE-C89A414BC781Q35010408-941E49C8-EA30-4A88-84B2-3EB8FAD8024CQ35197361-8FDF38A9-A4C8-4CD8-9128-AD9EC1CCDB9FQ38300286-0CF59E11-10CB-4935-9B6C-640269C24282Q38604015-CA7C5126-C065-4F74-844A-E3BB2FC80543Q38973656-55B0DC55-998E-49C5-8D64-B9F5330C31CAQ39240389-F441A912-E7F9-429F-9F35-65545EBBC588
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Management of portal hypertension in children.
@en
Management of portal hypertension in children.
@nl
type
label
Management of portal hypertension in children.
@en
Management of portal hypertension in children.
@nl
prefLabel
Management of portal hypertension in children.
@en
Management of portal hypertension in children.
@nl
P2860
P356
P1476
Management of portal hypertension in children.
@en
P2093
Philip Rosenthal
Roberto Gugig
P2860
P304
P356
10.3748/WJG.V18.I11.1176
P407
P577
2012-03-01T00:00:00Z